Counterfeit medicines: survey report
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Strasbourg
Council of Europe Publ.
2006
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | Literaturverz. S. 173 - 174 |
Beschreibung: | 239 S. Kt. |
ISBN: | 9789287158635 9287158630 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV023411732 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 080723s2006 b||| |||| 00||| eng d | ||
020 | |a 9789287158635 |9 978-92-871-5863-5 | ||
020 | |a 9287158630 |9 92-871-5863-0 | ||
035 | |a (DE-599)OBVAC05354983 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-Er8 | ||
084 | |a VW 5400 |0 (DE-625)147766:253 |2 rvk | ||
245 | 1 | 0 | |a Counterfeit medicines |b survey report |c [Council of Europe] |
264 | 1 | |a Strasbourg |b Council of Europe Publ. |c 2006 | |
300 | |a 239 S. |b Kt. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
500 | |a Literaturverz. S. 173 - 174 | ||
650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Fälschung |0 (DE-588)4016247-3 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
689 | 0 | 1 | |a Fälschung |0 (DE-588)4016247-3 |D s |
689 | 0 | |5 DE-604 | |
710 | 2 | |a Europarat |e Sonstige |0 (DE-588)36821-0 |4 oth | |
856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016594344&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-016594344 |
Datensatz im Suchindex
_version_ | 1804137800051720192 |
---|---|
adam_text | Contents
Executive summary 7
1. Introduction 13
2. Known current and estimated future market for counterfeit medicines 17
3. Trade issues concerning counterfeit medicines 33
4. Pharmaceutical regulation status with respect to manufacture,
distribution, storage and import/export/transit of active pharmaceutical
ingredients, bulk products and finished products 45
5. Analytical testing procedures for suspected counterfeit medicines 49
6. National regulatory authority co-operation 53
7. International regulatory authority co-operation 57
8. Regulatory authority, industry and wholesaler co-operation 61
9. Authorities, systems and procedures for detection of
counterfeit medicines 67
10. Legal provisions, enforcement, sanctions, and judicial, and intellectual
property procedures concerning unlicensed and counterfeit medicines 75
11. Adequacy of legal/judicial/administrative systems for dealing with
counterfeit medicines - The authority perspective 105
12. Adequacy of existing countermeasures to prevent medicines
counterfeiting and public health damage due to counterfeit medicines -
Theindustry and wholesaler perspective 107
13. Counterfeit medicine and pharmaceutical crime definitions 121
14. Adequacy of authority/wholesaler/manufacturer personnel training
concerning detection and control of counterfeit medicines 123
15. Conclusions and recommendations made by Council of Europe
survey respondents 125
16. Discussion and final conclusions 131
17. Recommendations for the implementation of legislative and
administrative measures against medicines counterfeiting 149
References 173
Acronyms 175
List of tables and charts 177
Appendices 181
5
|
adam_txt |
Contents
Executive summary 7
1. Introduction 13
2. Known current and estimated future market for counterfeit medicines 17
3. Trade issues concerning counterfeit medicines 33
4. Pharmaceutical regulation status with respect to manufacture,
distribution, storage and import/export/transit of active pharmaceutical
ingredients, bulk products and finished products 45
5. Analytical testing procedures for suspected counterfeit medicines 49
6. National regulatory authority co-operation 53
7. International regulatory authority co-operation 57
8. Regulatory authority, industry and wholesaler co-operation 61
9. Authorities, systems and procedures for detection of
counterfeit medicines 67
10. Legal provisions, enforcement, sanctions, and judicial, and intellectual
property procedures concerning unlicensed and counterfeit medicines 75
11. Adequacy of legal/judicial/administrative systems for dealing with
counterfeit medicines - The authority perspective 105
12. Adequacy of existing countermeasures to prevent medicines
counterfeiting and public health damage due to counterfeit medicines -
Theindustry and wholesaler perspective 107
13. Counterfeit medicine and pharmaceutical crime definitions 121
14. Adequacy of authority/wholesaler/manufacturer personnel training
concerning detection and control of counterfeit medicines 123
15. Conclusions and recommendations made by Council of Europe
survey respondents 125
16. Discussion and final conclusions 131
17. Recommendations for the implementation of legislative and
administrative measures against medicines counterfeiting 149
References 173
Acronyms 175
List of tables and charts 177
Appendices 181
5 |
any_adam_object | 1 |
any_adam_object_boolean | 1 |
building | Verbundindex |
bvnumber | BV023411732 |
classification_rvk | VW 5400 |
ctrlnum | (DE-599)OBVAC05354983 |
discipline | Chemie / Pharmazie |
discipline_str_mv | Chemie / Pharmazie |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01319nam a2200349 c 4500</leader><controlfield tag="001">BV023411732</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">080723s2006 b||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789287158635</subfield><subfield code="9">978-92-871-5863-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9287158630</subfield><subfield code="9">92-871-5863-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)OBVAC05354983</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-Er8</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VW 5400</subfield><subfield code="0">(DE-625)147766:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Counterfeit medicines</subfield><subfield code="b">survey report</subfield><subfield code="c">[Council of Europe]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Strasbourg</subfield><subfield code="b">Council of Europe Publ.</subfield><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">239 S.</subfield><subfield code="b">Kt.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturverz. S. 173 - 174</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Fälschung</subfield><subfield code="0">(DE-588)4016247-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Fälschung</subfield><subfield code="0">(DE-588)4016247-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Europarat</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)36821-0</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016594344&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016594344</subfield></datafield></record></collection> |
id | DE-604.BV023411732 |
illustrated | Illustrated |
index_date | 2024-07-02T21:27:50Z |
indexdate | 2024-07-09T21:18:03Z |
institution | BVB |
institution_GND | (DE-588)36821-0 |
isbn | 9789287158635 9287158630 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016594344 |
open_access_boolean | |
owner | DE-Er8 |
owner_facet | DE-Er8 |
physical | 239 S. Kt. |
publishDate | 2006 |
publishDateSearch | 2006 |
publishDateSort | 2006 |
publisher | Council of Europe Publ. |
record_format | marc |
spelling | Counterfeit medicines survey report [Council of Europe] Strasbourg Council of Europe Publ. 2006 239 S. Kt. txt rdacontent n rdamedia nc rdacarrier Literaturverz. S. 173 - 174 Arzneimittel (DE-588)4003115-9 gnd rswk-swf Fälschung (DE-588)4016247-3 gnd rswk-swf Arzneimittel (DE-588)4003115-9 s Fälschung (DE-588)4016247-3 s DE-604 Europarat Sonstige (DE-588)36821-0 oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016594344&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Counterfeit medicines survey report Arzneimittel (DE-588)4003115-9 gnd Fälschung (DE-588)4016247-3 gnd |
subject_GND | (DE-588)4003115-9 (DE-588)4016247-3 |
title | Counterfeit medicines survey report |
title_auth | Counterfeit medicines survey report |
title_exact_search | Counterfeit medicines survey report |
title_exact_search_txtP | Counterfeit medicines survey report |
title_full | Counterfeit medicines survey report [Council of Europe] |
title_fullStr | Counterfeit medicines survey report [Council of Europe] |
title_full_unstemmed | Counterfeit medicines survey report [Council of Europe] |
title_short | Counterfeit medicines |
title_sort | counterfeit medicines survey report |
title_sub | survey report |
topic | Arzneimittel (DE-588)4003115-9 gnd Fälschung (DE-588)4016247-3 gnd |
topic_facet | Arzneimittel Fälschung |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016594344&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT europarat counterfeitmedicinessurveyreport |